SCHEMBL27615010

SCHEMBL27615010

Cc1ncccc1C(CBr)C(=O)C(CBr)c1cccnc1C

nearest known ligand 0.42

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.42
MKNK1 Q9BUB5 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
GSK3B P49841 1/20 0.35
FAAH O00519 1/20 0.35
FFAR1 O14842 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27707669 0.83 P2RX7 (0.42) P2RX7MKNK1MKNK2FAAHFFAR1
SCHEMBL27735315 0.81 TRIM24 (0.38) GSK3B
SCHEMBL27714552 0.80 SMN1; SMN2 (0.43) FAAH
SCHEMBL6178335 0.80 P2RX7 (0.42) P2RX7
SCHEMBL666964 0.79 P2RX7 (0.45) P2RX7MKNK1MKNK2FFAR1
SCHEMBL11283979 0.77 MEN1 (0.38) P2RX7
SCHEMBL27615009 0.77 CYP1A2 (0.38) P2RX7GSK3B
SCHEMBL27549905 0.75 ESR1 (0.41)
SCHEMBL27596207 0.74 P2RX7 (0.32) P2RX7
SCHEMBL6181763 0.73 MEN1 (0.46) P2RX7FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100395234-C Novel CB1 receptor inverse agonists HOFFMANN LA ROCHE (CH) 2008-06-18 CN disclosed
CN-100381429-C Thiazole derivatives HOFFMANN LA ROCHE (CH) 2008-04-16 CN disclosed
CN-100363362-C Thiazole derivatives as NPY receptor antagonists HOFFMANN LA ROCHE (CH) 2008-01-23 CN disclosed
CN-101012193-A Novel CB 1 receptour inverse agonists HOFFMANN LA ROCHE (CH) 2007-08-08 CN disclosed
CN-1735593-A Novel CB1 receptor inverse agonists HOFFMANN LA ROCHE (CH) 2006-02-15 CN disclosed
CN-1675188-A Thiazole derivatives HOFFMANN LA ROCHE (CH) 2005-09-28 CN disclosed
CN-1639146-A Fused tricyclic heterocycles useful for the treatment of hyperproliferative diseases BAYER PHARMACEUTICALS CORP (US) 2005-07-13 CN disclosed
CN-1639158-A Thiazole derivatives as NPY receptor antagonists HOFFMANN LA ROCHE (CH) 2005-07-13 CN disclosed